Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection

• Main Authors: Jian Zhao, Wei Zhang, Jun Zhang, Yi Zhang, Wen-Jie Ma, Si-Yun Liu, Fu-Yu Li, Bin Song
• Format: Article
• Language: English
• Published: BMC 2020-09-01
• Series: BMC Cancer
• Subjects: Perihilar cholangiocarcinoma; AJCC; Prognosis; Overall survival; Curative intent resection
• Online Access: http://link.springer.com/article/10.1186/s12885-020-07357-4

Abstract Background Both the 7th and 8th editions of the American Joint Committee on Cancer (AJCC) staging system for perihilar cholangiocarcinoma (pCCA) had the same definition for T2a and T2b. But the value of this classification as prognostic factor remains unclear. Methods 178 patients with stage T2a or T2b who underwent curative intent resection for pCCA between Jan 2010 and Dec 2018 were enrolled. Relationships between survival and clinicopathological factors including patient demographics and tumor characteristics were evaluated using univariate and multivariate Cox regression analysis. The overall survival (OS) were calculated by Kaplan-Meier method. Results There was no significant difference in OS between T2a and T2b groups, and the median OS duration were 37 and 31 months (P = 0.354). Both the 7th and 8th edition of the AJCC TNM staging demonstrated a poor prognostic predictive performance. High level of preoperative AST (≥85.0 IU/L) and CA19–9 (≥1000 U/mL), vascular resection and lower pathological differentiation of the tumor were the independent predictors for poor survival after resection. Conclusion The newly released 8th edition of AJCC staging system demonstrated a poor ability to discriminate the prognosis of patients with stage T2a and T2b pCCA after resection.